Head-to-head for women
HealthRX vs REMEVi
HealthRX and REMEVi both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
HealthRX
Ranked #5 for women · Grade B
Luna Fit
Best for: Women who want a LegitScript-certified, physician-supervised program with both molecules, an oral-tablet route as well as injections, and transparent flat pricing with no insurance to navigate.
Visit HealthRXREMEVi
Ranked #31 for women · Grade B
Luna Fit
Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing.
Visit REMEViThe verdict for women
HealthRX and REMEVi tie on the Luna Fit Score at 85/100 apiece, so neither runs away with it. The right pick comes down to the factors that matter most to you — compare them below, or read the HealthRX scorecard and the REMEVi scorecard in full. If the answer is still neither, the alternatives to HealthRX we rank for women widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | HealthRX | REMEVi |
|---|---|---|
| Luna Fit Score | 85/100 · B | 85/100 · B |
| Overall rank | #5 | #31 |
| Semaglutide | $190/mo month-to-month ($99 first month, renews at $165) · $99/mo on a 12-month prepay ($1,188) | $199/mo |
| Tirzepatide | $239/mo month-to-month ($149 first month, renews at $214) · $179/mo on a 12-month prepay ($2,148) | $269/mo |
| Coverage | Not publicly listed | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Luna Fit
HealthRX
Ranked #5 · Grade B
What we like
- LegitScript-certified (a meaningful third-party trust signal) with physician-supervised care, not a prescription-only handoff
- Both molecules plus a rare oral GLP-1 tablet — real optionality for the needle-averse and for insulin-resistant PCOS
- Transparent, no-insurance flat pricing — injectable GLP-1 around $189/mo, oral tablet around $239/mo, GLP+GIP around $349/mo
The caveats
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- Some tiers are company-stated and the public site is thin, so a few figures can't be verified live
- Brand-name tiers are pass-through and expensive — brand Ozempic runs about $1,299/mo
Luna Fit
REMEVi
Ranked #31 · Grade B
What we like
- LegitScript-accredited and available in all 50 states
- Both molecules disclosed, tirzepatide for insulin-resistant PCOS
- Clear, predictable pricing
The caveats
- Higher-end pricing — $199 semaglutide, $269 tirzepatide
- No oral or brand-name option; general program without hormone specialization
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither HealthRX nor REMEVi is only worth comparing with the other. HealthRX is also written up against CoreAge Rx, 8 points apart on the Luna Fit Score — see the HealthRX–CoreAge Rx head-to-head. REMEVi is also written up against CoreAge Rx, 8 points apart — see the REMEVi–CoreAge Rx head-to-head.
- HealthRX vs CoreAge Rx
- HealthRX vs Enhance MD
- HealthRX vs yourEra
- REMEVi vs Sesame Care
- REMEVi vs MadeMed
- REMEVi vs Trimi
Or browse the full comparison hub.